ORIGINAL ARTICLE, The Immunomodulator Vasoactive Intestinal Peptide (VIP) Does Not Affect Experimental Autoimmune Uveitis (EAU) in B10.RIII Mice

Author： Chen Jun   Vistica Barbara   Wiggert Barbara   Chan Chi-Chao   Gery Igal  

Publisher： Informa Healthcare

ISSN： 0927-3948

Source： Ocular Immunology and Inflammation, Vol.13, Iss.1, 2005-03, pp. : 13-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor

By Rameshwar P.   Gascon P.   Oh H.S.   Denny T.N.   Zhu G.   Ganea D.  

Experimental Hematology, Vol. 30, Iss. 9, 2002-09 ,pp. : 1001-1009

Elsevier

Access to resources Recommend Favorite

Vasoactive Intestinal Polypeptide Suppressed Experimental Autoimmune Encephalomyelitis by Inhibiting T Helper 1 Responses

By Li Haiyan   Mei Yunhua   Wang Ying   Xu Lingyun  

Journal of Clinical Immunology, Vol. 26, Iss. 5, 2006-09 ,pp. : 430-437

Springer Publishing Company

Access to resources Recommend Favorite

Relapsing and Remitting Experimental Autoimmune Encephalomyelitis in B Cell Deficient Mice

By Dittel B.N.   Urbania T.H.   Janeway C.A.  

Journal of Autoimmunity, Vol. 14, Iss. 4, 2000-06 ,pp. : 311-318

Academic Press

Access to resources Recommend Favorite

Experimental autoimmune myasthenia gravis induction in B cell-deficient mice

By Shi F-D.  

International Immunology, Vol. 10, Iss. 9, 1998-09 ,pp. : 1359-1365

Oxford University Press

Access to resources Recommend Favorite

The Role of A-Crystallin in Experimental Autoimmune Uveitis

By  

Current Molecular Medicine, Vol. 15, Iss. 6, 2015-01 ,pp. : 558-564

Bentham Science Publishers

Access to resources Recommend Favorite